Skip to main content
Glama

Mychem

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark this as readOnly, idempotent, and non-destructive, so the description adds behavioral context beyond those. It discloses parallel fan-out across multiple upstream sources, the sources_used/sources_failed contract, that an empty section means genuine 'no data' rather than a bug, FDA-licensed biologics only, and the GDELT→GNews fallback. These details tell the agent exactly what to expect and how to interpret results.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense, with the purpose and preference directive front-loaded before the detailed source/output enumeration. It lacks crisp paragraph structure, but every sentence contributes: examples, fan-out sources, return fields, no-data semantics, accepted inputs, and edge-case behavior. Minor redundancy with the schema's type/value explanation keeps it from a 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description carries the full burden of explaining return values. It does so comprehensively: CIK/company_name, resolved_from/resolved_to, recent_filings URIs, fundamentals, patents, contracts, FDA products, hiring, news, LEI, and the sources_used/sources_failed mechanism. It also covers fallback behavior, private-company handling, and expected empty sections, making the tool fully callable without external assumptions.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and the schema already contains rich descriptions for both 'type' and 'value', including the interchangeability of 'company' and 'ticker' and accepted forms (ticker, CIK, name). The description mostly restates this with examples and adds output-related resolution behavior (resolved_from/resolved_to), but it does not meaningfully expand the parameter semantics beyond the schema. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings ('Tell me about X', 'research Acme', 'company profile for Microsoft') and states a precise purpose: 'full cross-source profile of a US public company in ONE parallel call.' It names the exact output sections (filings, fundamentals, patents, contracts, etc.), which sharply differentiates it from narrower single-source lookups and sibling tools like compare_entities or resolve_entity.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly instructs 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view,' telling the agent when to select this tool instead of alternatives. It also addresses edge cases: a private company returns resolved:false with a notes line rather than a failure, and type accepts 'company' or 'ticker' interchangeably. This is strong when-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Mychem toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

The set contains several near-duplicate entry points (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded) plus a dense family of polymarket_* and chemical lookup tools whose boundaries are subtle. An agent can easily pick the wrong router variant, edge-scanning tool, or chemical search tool.

Naming Consistency3/5

Snake_case is used throughout, but naming style is mixed: some tools are verb-first (query, resolve_entity, validate_claim), some are noun/domain-first (entity_profile, recent_changes, polymarket_arbitrage), and the ask_pipeworx variants use suffixes instead of a consistent verb pattern. It is readable, but there is no predictable convention beyond snake_case.

Tool Count2/5

34 tools is well past the comfortable range, and the count is especially hard to justify because they span unrelated domains: chemistry lookups, a Pipeworx data gateway, prediction-market analytics, memory, subscriptions, AI-visibility checks, and npm dependency scanning. Many of these have no obvious connection to the 'Mychem' name or to each other.

Completeness4/5

Within each contained workflow the surface is fairly complete: chemistry has search/fetch/metadata, Pipeworx has lookup/research/discovery/validation, subscriptions and memory both have lifecycle coverage, and the Polymarket family covers research, edge detection, persistence, and fill risk. Some minor gaps exist (no general web retrieval or execution/trading action), but agents can work around them.

Resources